Live Breaking News & Updates on Biolase

Stay updated with breaking news from Biolase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the. ....

Michael Polyviou Todd Kehrli , Steve Fooshee , Source Biolase Inc , Exchange Commission , Biolase Inc , Prnewswire Biolase Inc , Receives Overwhelmingly Positive Dentist Feedback , Unanimous Approval During Independently , Performance Satisfaction , Wider Adoption , Plus All Tissue , Advanced Laser , Russell Morrow , Chief Dental Officer , Waterlase Express , Private Litigation Reform Act , Annual Report ,

BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with. ....

New York , United States , Michael Polyviou Todd Kehrli , Maxim Group , Source Biolase Inc , Syndicate Department , Biolase Inc , Exchange Commission , Prnewswire Biolase Inc , Private Litigation Reform Act , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , Stock Offering ,

Short Interest in BIOLASE, Inc. (NASDAQ:BIOL) Expands By 70.6%

BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 275,700 shares, an increase of 70.6% from the August 31st total of 161,600 shares. Approximately 29.6% of the shares of the company are sold short. Based on […] ....

United States , Avantax Planning Partners Inc , Biolase Inc , Perkins Capital Management Inc , Acadian Asset Management , Walleye Capital , Get Free Report , Capital Management , Asset Management , Planning Partners , State Street Corp , Street Corp , Nasdaq Biol ,

BIOLASE, Inc. (NASDAQ:BIOL) Short Interest Down 87.2% in July

BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 399,400 shares, a decrease of 87.2% from the July 15th total of 3,110,000 shares. Currently, 40.2% of the company’s stock are sold short. Based on an average […] ....

United States , Acadian Asset Management , Renaissance Technologies , Biolase Inc , Perkins Capital Management Inc , Avantax Planning Partners Inc , Get Free Report , Capital Management , Asset Management , Planning Partners , Street Corp , Street Capital , Nasdaq Biol ,

BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30,. ....

United States , Michael Polyviou Todd Kehrli , John Beaver , Waterlase Trial Program , Source Biolase Inc , Biolase Inc , American Academy Of Facial Aesthetics , Exchange Commission , Experience Positive Momentum , Achieve Improved Net Income , Positive Adjusted , Second Half , Trial Program , Chief Executive Officer , American Academy , Facial Aesthetics , Year Financial Guidance , Waterlase Express , Private Securities Litigation Reform Act , Operating Activities , Investing Activities , Financing Activities , Seriesh Convertible Preferred Stock , Loss Per Share , Medical Equipment , Health Care Amp Hospitals ,